Related Experiment Video
Updated: Sep 16, 2025

14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
14.2K
Midterm Outcomes of Graft Insertion Technique for Redo Aortic Root Surgery
Takuya Narita1,2, Ai Ishizawa3, Nobuyuki Inoue4
1Cardiovascular Surgery, Chiba-Nishi General Hospital, Matsudo, Chiba, Japan.
Summary
The graft insertion technique (GIT) offers a feasible option for complex left ventricular outflow tract and aortic root reconstruction in high-risk patients. Midterm follow-up showed no adverse aortic events in survivors.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Surgical Innovation
Background:
- Reconstruction of the left ventricular outflow tract (LVOT) and aortic root presents challenges, particularly in high-risk patients.
- Existing techniques may have limitations in complex cases requiring redo surgery.
Purpose of the Study:
- To evaluate the midterm outcomes of the graft insertion technique (GIT) for LVOT and aortic root reconstruction.
- To assess the incidence of adverse aortic events (AAEs) following GIT.
Main Methods:
- A consecutive series of 14 high-risk patients underwent GIT for LVOT and aortic root reconstruction between August 2014 and March 2024.
- Indications included prosthetic valve endocarditis (9 patients) and noninfectious pseudoaneurysm (5 patients).
- Mean EuroSCORE II was 28.8 ± 17.6, with seven patients undergoing aortic root surgery.
Main Results:
- Mean operation time was 504 ± 87 minutes, with cardiopulmonary bypass and aortic cross-clamp times of 311 ± 41 and 240 ± 45 minutes, respectively.
- Operative mortality was 7.1% (1 patient), and 35.7% (5 patients) died within the first year.
- No surviving patients experienced recurrent endocarditis or cardiovascular events/infections after the second year. Crucially, no AAEs were observed on CT during follow-up.
Conclusions:
- The graft insertion technique (GIT) is a viable alternative for complex aortic root and LVOT reconstruction in high-risk surgical candidates.
- GIT demonstrated promising midterm safety, with no observed adverse aortic events in surviving patients.

